BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20738325)

  • 1. Leptin induces hypertrophy through activating the peroxisome proliferator-activated receptor α pathway in cultured neonatal rat cardiomyocytes.
    Hou N; Luo MS; Liu SM; Zhang HN; Xiao Q; Sun P; Zhang GS; Luo JD; Chen MS
    Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1087-95. PubMed ID: 20738325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptin induces hypertrophy via endothelin-1-reactive oxygen species pathway in cultured neonatal rat cardiomyocytes.
    Xu FP; Chen MS; Wang YZ; Yi Q; Lin SB; Chen AF; Luo JD
    Circulation; 2004 Sep; 110(10):1269-75. PubMed ID: 15313952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
    Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I
    Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simvastatin inhibits leptin-induced hypertrophy in cultured neonatal rat cardiomyocytes.
    Hu TP; Xu FP; Li YJ; Luo JD
    Acta Pharmacol Sin; 2006 Apr; 27(4):419-22. PubMed ID: 16539841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasopressin promotes cardiomyocyte hypertrophy via the vasopressin V1A receptor in neonatal mice.
    Hiroyama M; Wang S; Aoyagi T; Oikawa R; Sanbe A; Takeo S; Tanoue A
    Eur J Pharmacol; 2007 Mar; 559(2-3):89-97. PubMed ID: 17275806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor beta/delta activation inhibits hypertrophy in neonatal rat cardiomyocytes.
    Planavila A; Rodríguez-Calvo R; Jové M; Michalik L; Wahli W; Laguna JC; Vázquez-Carrera M
    Cardiovasc Res; 2005 Mar; 65(4):832-41. PubMed ID: 15721863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ERK1/2/PPARα/SCAD signal pathways on cardiomyocyte hypertrophy induced by insulin-like growth factor 1 and phenylephrine.
    Huang Q; Huang J; Zeng Z; Luo J; Liu P; Chen S; Liu B; Pan X; Zang L; Zhou S
    Life Sci; 2015 Mar; 124():41-9. PubMed ID: 25636810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Peroxisome Proliferator Activated Receptor α (PPAR α) for the Prevention of Mitochondrial Impairment and Hypertrophy in Cardiomyocytes.
    Kar D; Bandyopadhyay A
    Cell Physiol Biochem; 2018; 49(1):245-259. PubMed ID: 30138942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-dependence of cardiomyocyte differentiation disturbed by peroxisome proliferator-activated receptor alpha inhibitor GW6471 in murine embryonic stem cells in vitro.
    Ding L; Liang XG; Lou YJ
    Acta Pharmacol Sin; 2007 May; 28(5):634-42. PubMed ID: 17439719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An autocrine role for leptin in mediating the cardiomyocyte hypertrophic effects of angiotensin II and endothelin-1.
    Rajapurohitam V; Javadov S; Purdham DM; Kirshenbaum LA; Karmazyn M
    J Mol Cell Cardiol; 2006 Aug; 41(2):265-74. PubMed ID: 16806260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decrease of peroxisome proliferator-activated receptor delta expression in cardiomyopathy of streptozotocin-induced diabetic rats.
    Yu BC; Chang CK; Ou HY; Cheng KC; Cheng JT
    Cardiovasc Res; 2008 Oct; 80(1):78-87. PubMed ID: 18573863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine monophosphate-activated protein kinase inhibits cardiac hypertrophy through reactivating peroxisome proliferator-activated receptor-alpha signaling pathway.
    Meng RS; Pei ZH; Yin R; Zhang CX; Chen BL; Zhang Y; Liu D; Xu AL; Dong YG
    Eur J Pharmacol; 2009 Oct; 620(1-3):63-70. PubMed ID: 19699196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelin-1-Induced Cell Hypertrophy in Cardiomyocytes is Improved by Fenofibrate: Possible Roles of Adiponectin.
    Jen HL; Yin WH; Chen JW; Lin SJ
    J Atheroscler Thromb; 2017 May; 24(5):508-517. PubMed ID: 27629528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor-gamma ligands 15-deoxy-delta(12,14)-prostaglandin J2 and pioglitazone inhibit hydroxyl peroxide-induced TNF-alpha and lipopolysaccharide-induced CXC chemokine expression in neonatal rat cardiac myocytes.
    Liu J; Xia Q; Zhang Q; Li H; Zhang J; Li A; Xiu R
    Shock; 2009 Sep; 32(3):317-24. PubMed ID: 19174742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the peroxisome proliferator-activated receptor alpha pathway potentiates interleukin-1 receptor antagonist production in cytokine-treated chondrocytes.
    François M; Richette P; Tsagris L; Fitting C; Lemay C; Benallaoua M; Tahiri K; Corvol MT
    Arthritis Rheum; 2006 Apr; 54(4):1233-45. PubMed ID: 16572457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II downregulates the fatty acid oxidation pathway in adult rat cardiomyocytes via release of tumour necrosis factor-alpha.
    Pellieux C; Montessuit C; Papageorgiou I; Lerch R
    Cardiovasc Res; 2009 May; 82(2):341-50. PubMed ID: 19131364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reactive oxygen species mediate cultured neonatal rat cardiac myocyte hypertrophy induced by endothelin-1].
    Wang YZ; Luo JD
    Sheng Li Xue Bao; 2004 Jun; 56(3):403-6. PubMed ID: 15224158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine D2 receptor stimulation inhibits angiotensin II-induced hypertrophy in cultured neonatal rat ventricular myocytes.
    Li H; Shi S; Sun YH; Zhao YJ; Li QF; Li HZ; Wang R; Xu CQ
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):312-8. PubMed ID: 18986329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbacyclin induces carnitine palmitoyltransferase-1 in cardiomyocytes via peroxisome proliferator-activated receptor (PPAR) delta independent of the IP receptor signaling pathway.
    Kuroda T; Hirota H; Fujio Y; Sugiyama S; Masaki M; Hiramoto Y; Shioyama W; Okamoto K; Hori M; Yamauchi-Takihara K
    J Mol Cell Cardiol; 2007 Jul; 43(1):54-62. PubMed ID: 17540403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fenofibrate suppresses growth of the human hepatocellular carcinoma cell via PPARα-independent mechanisms.
    Yamasaki D; Kawabe N; Nakamura H; Tachibana K; Ishimoto K; Tanaka T; Aburatani H; Sakai J; Hamakubo T; Kodama T; Doi T
    Eur J Cell Biol; 2011 Aug; 90(8):657-64. PubMed ID: 21514001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.